Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Disruptions in mammary stem cell division can lead to cancer, but targeting these processes might help treat breast cancer.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Personalized supplements are important for women's health, but hormone therapy can increase cancer and heart risks.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Eclipta alba extract may help fight cancer and has antioxidant benefits without being toxic.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Diagnosing mycosis fungoides, a rare skin cancer, is difficult in elderly adults and requires careful examination to avoid mistaking it for less serious skin conditions.

LncRNA Xist is crucial for X-chromosome inactivation and may be a target for treating diseases like cancer and heart issues.

The new drug delivery system improves exemestane's absorption and effectiveness.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.